IL-6 impairs myogenic differentiation by downmodulation of p90RSK/eEF2 and mTOR/p70S6K axes, without affecting AKT activity.

Abstract : IL-6 is a multifaceted pleiotropic cytokine, which is produced by a variety of cell types and targets different cells and tissues. In physiological conditions, IL-6 can be locally and transiently produced by skeletal muscle and plays an important role in muscle homeostasis. Circulating IL-6 levels are normally very low or undetectable but are dramatically increased in several pathologic conditions. In this study, we aimed to define the potential molecular mechanisms underlying the effects of IL-6 on myogenic program. We explored the molecular mechanisms through which exogenous IL-6, or the conditioned medium from the murine C-26 adenocarcinoma cells (a cellular model that secretes high levels of IL-6 and induces cancer cachexia in mice), interferes with the myogenic program. Our study revealed that IL-6 induces the activation of the Stat3 signaling and promotes the downmodulation of the p90RSK/eEF2 and mTOR/p70S6K axes, while it does not affect the activation of AKT. We thus identified potential molecular mediators of the inhibitory effects of IL-6 on myogenic program.
Type de document :
Article dans une revue
BioMed Research International , Hindawi Publishing Corporation, 2014, 2014, pp.206026. 〈10.1155/2014/206026〉
Liste complète des métadonnées

Littérature citée [33 références]  Voir  Masquer  Télécharger

https://hal-riip.archives-ouvertes.fr/pasteur-01182462
Contributeur : Istituto Pasteur Fondazione Cenci Bolognetti <>
Soumis le : vendredi 31 juillet 2015 - 15:01:08
Dernière modification le : lundi 5 février 2018 - 15:22:13
Document(s) archivé(s) le : dimanche 1 novembre 2015 - 10:34:03

Fichier

BMRI2014-206026.pdf
Fichiers produits par l'(les) auteur(s)

Licence


Distributed under a Creative Commons Paternité 4.0 International License

Identifiants

Collections

Citation

Michele Pelosi, Manuela De Rossi, Laura Barberi, Antonio Musarò. IL-6 impairs myogenic differentiation by downmodulation of p90RSK/eEF2 and mTOR/p70S6K axes, without affecting AKT activity.. BioMed Research International , Hindawi Publishing Corporation, 2014, 2014, pp.206026. 〈10.1155/2014/206026〉. 〈pasteur-01182462〉

Partager

Métriques

Consultations de la notice

91

Téléchargements de fichiers

79